UK permits first clinical trial for depression treatment with DMT

The Imperial College London's Centre for Psychedelic Research will run the first clinical trial of depression treatment with the psychedelic and illegal substance dimethyltryptamine (DMT). It will be held in in collaboration with Small Pharma, with a neuropharmaceutical company.

Small Pharma stated that the approval is a "truly ground-breaking moment" in the treatment of depression and the chief medical and scientific officer at the company, Carol Routledge, has added that she believes that "Psychedelic assisted therapy will revolutionise the treatment of depression because it gets right to the root cause of the illness".

co-founder of Pendect. Trying to protect free speech and democracies by creating a global news platform that is built through expert contribution. In love with vinyl, psytrance and penguins.
Card reviewed by: @ericof